SCHEMBL22148646

SCHEMBL22148646

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4c(-n5c6ccccc6c6ccccc65)c(-n5c6ccccc6c6ccccc65)nc(-n5c6ccccc6c6ccccc65)c4-n4c5ccccc5c5ccccc54)c3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ATM Q13315 2/20 0.35
ACP1 P24666 2/20 0.35
NR1I3 Q14994 3/20 0.35
ABCG2 Q9UNQ0 4/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
CYP1A2 P05177 4/20 0.33
CYP3A4 P08684 4/20 0.33
CYP2C9 P11712 4/20 0.33
CYP2D6 P10635 3/20 0.33
CYP2B6 P20813 2/20 0.33
AHR P35869 2/20 0.33
CYP2C19 P33261 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22148784 0.92 ACP1 (0.33) L3MBTL1KDM4EATMACP1ABCG2
SCHEMBL22148774 0.92 MEN1 (0.42) L3MBTL1KDM4EATMNR1I3MEN1
SCHEMBL22148533 0.91 MEN1 (0.42) L3MBTL1KDM4EMEN1KMT2AALDH1A1
SCHEMBL30709567 0.91 MAOA (0.38) ATMMEN1KMT2AALDH1A1MAPT
SCHEMBL30709563 0.91 LMNA (0.32) MEN1KMT2AALDH1A1MAPTCYP1A2
SCHEMBL22148822 0.91 MAPT (0.35) L3MBTL1KDM4ENR1I3ABCG2MEN1
SCHEMBL21085320 0.90 KMT2A (0.38) L3MBTL1KDM4EATMACP1ABCG2
SCHEMBL21888539 0.88 L3MBTL1 (0.39) L3MBTL1KDM4EATMACP1ABCG2
SCHEMBL30339340 0.88 L3MBTL1 (0.39) L3MBTL1KDM4EATMACP1ABCG2
SCHEMBL23869354 0.88 ACP1 (0.35) L3MBTL1KDM4EATMACP1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 L3MBTL1 1938/4885KDM4E 4409/4885ATM 2778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.